Showing 5 of 5 recruiting trials for “Acute monoblastic/monocytic leukemia”
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
👨⚕️ Anna Halpern, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Mar 2020View details ↗
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
👨⚕️ Mary-Elizabeth Percival, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Nov 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →